NextCell Pharma AB
Stem and stromal cells are expected to revolutionize the treatment of today’s severe and incurable diseases. NextCell develops pioneering stromal cell therapies for the treatment of autoimmune and inflammatory diseases. NextCell's drug candidate, ProTrans, is at the forefront of our development for the treatment of type 1 diabetes.
Contact
+46 873 555 95
Hälsovägen 7 8tr, 141 57 Huddinge, Sweden